Home›Legal›Tirzepatide in Texas
Tirzepatide in Texas: Legal Status & Provider Guide (2026)
Quick Answer
Tirzepatide is a prescription substance in the United States. Tirzepatide is an FDA-approved dual GIP/GLP-1 receptor agonist. The compounding shortage exemption expired in early 2025. Current federal law generally prohibits compounded tirzepatide outside of narrow exceptions. Providers offering compounded tirzepatide should have clear documentation of their legal basis. In Texas, compounding is governed by the Texas State Board of Pharmacy (TSBP). In Texas, physician assistants and nurse practitioners with prescriptive authority can prescribe compounded medications including peptides. Prescribers must hold an active Texas license. Telemedicine prescribing of controlled substances and certain compounded medications is permitted under Texas Medical Board rules with specific conditions.
Federal Legal Status
FDA Approval Status
FDA-approved as Mounjaro (type 2 diabetes, 2022) and Zepbound (chronic weight management, 2023). FDA declared the tirzepatide shortage resolved in December 2024.
Compounding Pharmacy Rules (Federal)
Compounded tirzepatide was broadly permitted during the shortage period. Following FDA's shortage resolution in December 2024, 503B outsourcing facilities had until February 18, 2025, and 503A pharmacies until March 19, 2025, to wind down compounding. As of mid-2025, compounded tirzepatide is generally prohibited except for narrow clinical exceptions under a valid prescription.
Also Known As
Mounjaro · Zepbound
Primary Research Areas
- Weight management
- Type 2 diabetes
- Metabolic health
- Insulin resistance
Texas Pharmacy Board & Compounding Rules
Regulator
Compounding Overview
Texas is home to one of the largest compounding pharmacy industries in the country, with detailed rules set by the Texas State Board of Pharmacy (TSBP). Texas 503A pharmacies may compound non-FDA-approved peptides under certain conditions, though federal FDA guidance takes precedence for pharmacies participating in the national regulatory framework. Texas-specific rules address sterile compounding standards, USP 797 compliance, and registration requirements for non-resident pharmacies shipping into the state.
Notable Rules
- Texas TSBP requires sterile compounding facilities to comply with USP 797 standards.
- Non-resident (out-of-state) pharmacies shipping compounded products into Texas must be registered with the TSBP.
- Texas prohibits the sale of prescription-only compounded products without a valid prescription.
- The Texas Medical Board regulates prescribing standards for telemedicine encounters including peptide programs.
Prescribing Requirements in Texas
In Texas, physician assistants and nurse practitioners with prescriptive authority can prescribe compounded medications including peptides. Prescribers must hold an active Texas license. Telemedicine prescribing of controlled substances and certain compounded medications is permitted under Texas Medical Board rules with specific conditions.
About Tirzepatide
Tirzepatide is a novel dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist developed by Eli Lilly. It has demonstrated significant efficacy in clinical trials for both glycemic control and weight reduction, with some studies showing superior weight loss compared to semaglutide.
For more research information, mechanism of action, and provider availability, see the Tirzepatide research profile on PeptideBase.
Frequently Asked Questions
- Is compounded tirzepatide legal in 2026?
- FDA declared the tirzepatide shortage resolved in December 2024. Wind-down periods ended in Q1 2025. As of mid-2025, compounded tirzepatide is generally prohibited except for documented clinical exceptions. Patients should verify the legal basis with their provider.
- What is the difference between Mounjaro and Zepbound?
- Both contain tirzepatide. Mounjaro is FDA-approved for type 2 diabetes management; Zepbound is approved for chronic weight management in adults with obesity or overweight with a related condition. The drugs are chemically identical.
Tirzepatide Providers in Texas
No providers currently listed in Texas for Tirzepatide. Browse the full directory to find providers offering Tirzepatide.
Browse all Tirzepatide providers →Tirzepatide Legal Status in Other States
Pharmacy board rules and compounding regulations vary by state. Compare Tirzepatide legal status across other major markets:
Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .